Compare ABSI & CLBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABSI | CLBK |
|---|---|---|
| Founded | 2011 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 997.8M | 1.1B |
| IPO Year | 2021 | 2026 |
| Metric | ABSI | CLBK |
|---|---|---|
| Price | $9.93 | $11.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 1 |
| Target Price | $6.96 | ★ $17.00 |
| AVG Volume (30 Days) | 2.5M | ★ 8.7M |
| Earning Date | 05-07-2026 | 04-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.64 | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | ★ $4,534,000.00 | N/A |
| Revenue This Year | $215.96 | $3.97 |
| Revenue Next Year | $319.10 | $11.43 |
| P/E Ratio | ★ N/A | $43.03 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.24 | $10.51 |
| 52 Week High | $12.06 | $25.83 |
| Indicator | ABSI | CLBK |
|---|---|---|
| Relative Strength Index (RSI) | 60.84 | 33.48 |
| Support Level | $2.56 | $10.61 |
| Resistance Level | $12.06 | $18.70 |
| Average True Range (ATR) | 0.57 | 0.27 |
| MACD | 0.13 | 0.42 |
| Stochastic Oscillator | 93.80 | 74.83 |
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a customer service-focused institution. The company offers traditional financial services to businesses and consumers in its market areas. It attracts deposits from the general public and uses those funds to originate various loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans. The company also offers title insurance through its wholly owned subsidiary and provides a broad range of insurance products, including personal and business lines of insurance, mainly to customers and New Jersey residents.